Behavioural and neuropsychological problems in refractory paediatric epilepsies

Marc J C Boel1

  • 1Rehabilitation and Epilepsy Unit, Reebergenlaan 4, B-2242 Pulderbos, Belgium. marc.boel@revapulderbos.be

Insights

This study investigated behavioral issues in children with refractory epilepsy. Pervasive disorders and attentional problems were common, with mental decline observed in 15% of patients.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Child Psychology

Background:

  • Refractory epilepsy in children presents complex challenges.
  • Understanding associated behavioral and neuropsychological profiles is crucial for effective management.
  • Previous research has indicated links between epilepsy types and specific behavioral issues.

Purpose of the Study:

  • To explore correlations between different epilepsy categories and behavioral profiles in children.
  • To identify the most frequent neuro-behavioral correlates in pediatric epilepsy.
  • To investigate the prevalence of mental decline associated with the epileptic process.

Main Methods:

  • Retrospective analysis of 573 children with refractory epilepsy admitted to a residential unit (1984-2000).
  • Assessment of associated behavioral and neuropsychological profiles.
  • Categorization of epilepsy types and associated neuro-behavioral findings.

Main Results:

  • The most frequent neuro-behavioral correlates included pervasive disorders (8%), attentional problems (7.5%), loss of self-esteem (9%), and self-induction of seizures (7%).
  • Pervasive disorders were significantly more common in secondary generalized epilepsies.
  • Mental decline was observed in 15% of children, particularly those with Lennox-Gastaut syndrome, West syndrome, severe myoclonic epilepsy of infancy, and continuous spikes and slow waves during slow wave sleep.
  • Self-induction of seizures was more prevalent in females.

Conclusions:

  • Specific epilepsy types are associated with distinct behavioral and neuropsychological profiles in children.
  • Refractory epilepsy can lead to significant neuro-behavioral challenges, including pervasive disorders and mental decline.
  • Further research is warranted to develop targeted interventions for these comorbidities.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...